In what is bound to be viewed as a significant setback, the results of vaccine trials aimed at removing amyloid β plaques from the brains of Alzheimer's sufferers, have failed to prevent or reverse dementia. The disappointing news appears in the July 19 edition of The Lancet
Professor Clive Holmes and his team from the Memory Assessment and Research Centre, Moorgreen Hospital, Southampton, UK, found that plaque removal showed some evidence of disease modification but had little...
